Florida Dialysis Centers Market Size, Share & Trends Analysis Report 2023: A $1.3 Billion Market by 2030 – Escalating Demand for Dialysis Units Propelling Growth – ResearchAndMarkets.com

The “Florida Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-Center, In-Home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The Florida dialysis centers market size…

Read MoreFlorida Dialysis Centers Market Size, Share & Trends Analysis Report 2023: A $1.3 Billion Market by 2030 – Escalating Demand for Dialysis Units Propelling Growth – ResearchAndMarkets.com

Precision Fermentation Fuels Growth in Ophthalmic Viscoelastic Devices Market: Opportunities and Key Segments – ResearchAndMarkets.com

The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033“ report has been added to ResearchAndMarkets.com’s offering. This report provides a comprehensive analysis of the Ophthalmic Viscoelastic Devices (OVD)…

Read MorePrecision Fermentation Fuels Growth in Ophthalmic Viscoelastic Devices Market: Opportunities and Key Segments – ResearchAndMarkets.com

Emulate Publishes Novel Framework to Pave the Way for the Integration of Liver-Chip Technology into Pharmaceutical Safety Assessment

Emulate, Inc., the leading provider of next-generation in vitro models, today announced the publication “Integrating Liver-Chip Data into Pharmaceutical Decision-Making Processes” in Expert Opinion on Drug Discovery. The article introduces a decision-making framework that includes two guidelines for researchers to use in…

Read MoreEmulate Publishes Novel Framework to Pave the Way for the Integration of Liver-Chip Technology into Pharmaceutical Safety Assessment

Global Cell Freezing Media Market to Reach $291.3 Million by 2030 – Driven by Rising Adoption of Ready-to-Use Freezing Media – ResearchAndMarkets.com

The “Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. This report projects that the global…

Read MoreGlobal Cell Freezing Media Market to Reach $291.3 Million by 2030 – Driven by Rising Adoption of Ready-to-Use Freezing Media – ResearchAndMarkets.com

Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and post-essential thrombocythemia), in adults with anemia. Ojjaara is a…

Read MoreOjjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia

Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new analyses from studies of sotatercept, Merck’s novel investigational activin signaling inhibitor biologic, for adults with pulmonary arterial hypertension (PAH) (WHO Group 1) at the…

Read MoreMerck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

European Commission Expands Merck’s ERVEBO® [Ebola Zaire Vaccine, (rVSVΔG-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved an expanded indication for ERVEBO for active immunization of individuals 1 year of age or older to protect…

Read MoreEuropean Commission Expands Merck’s ERVEBO® [Ebola Zaire Vaccine, (rVSVΔG-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older

CVS Health announces additional responsibilities for executive leadership team members

 CVS Health® Corporation (NYSE: CVS) today announced additional responsibilities for several members of the company’s executive leadership team, effective immediately: “At a time when we are accelerating our strategy to deliver superior health experiences for consumers, we are advancing leaders who…

Read MoreCVS Health announces additional responsibilities for executive leadership team members

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation) for individuals 12 years and older and granted emergency use authorization for individuals 6 months…

Read MorePfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity

Eczacıbaşı Monrol Nuclear Products Co. (Monrol), one of the world’s leading radiopharmaceutical producers, has decided to invest 35 million Euros to increase its production capacity for non-carrier-added Lutetium-177 (n.c.a. Lu-177) in response to growing global demand for this product. Monrol,…

Read MoreMonrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity

DirectMed Parts & Service Announces Partnership and Investment in Technical Prospects

DirectMed Parts & Service (“DirectMed”), a leading medical imaging parts, systems, and service company, and portfolio company of NMS Capital (“NMS”), announced today that it has acquired Technical Prospects, LLC (“Technical Prospects” or the “Company”), a leading provider of parts,…

Read MoreDirectMed Parts & Service Announces Partnership and Investment in Technical Prospects